Cleveland Clinic researchers have discovered a key mechanism used by Kaposi’s sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV8), to induce cancer.
ViiV takes steps to widen access to HIV prevention drug, but continues to encounter criticism
Responding to growing pressure, ViiV Healthcare announced steps to widen access to its HIV prevention medicine in low- and middle-income countries, marking the second time